Bolivia, Plurinational State of vs Singapore: Treatment success rate for patients treated for MDR-TB
Bolivia, Plurinational State of
42.0%
in 2022
Singapore
39.0%
in 2022
Bolivia, Plurinational State of rank
149th
Singapore rank
150th
Treatment success rate for patients treated for MDR-TB over time
- Bolivia, Plurinational State of
- Singapore
How they compare
Bolivia, Plurinational State of currently reports 42.0% against 39.0% in Singapore, a difference of 3.0%.
That makes Bolivia, Plurinational State of's figure about 1.1 times Singapore's.
The two have swapped places 3 times across 16 shared years of data; in 2007 it was Singapore ahead.
Bolivia, Plurinational State of ranks 149th and Singapore ranks 150th of 163 countries.
Across the 3 decades both report, Bolivia, Plurinational State of averaged higher in 2 and Singapore in 1.
Head to head by decade
| Decade | Bolivia, Plurinational State of | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 66.7% | 91.7% | 25.0% | Singapore |
| 2010s | 62.2% | 52.9% | 9.3% | Bolivia, Plurinational State of |
| 2020s | 52.0% | 36.7% | 15.3% | Bolivia, Plurinational State of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Bolivia, Plurinational State of or Singapore?
- Bolivia, Plurinational State of, at 42.0% against 39.0% in Singapore as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Bolivia, Plurinational State of and Singapore?
- 3.0%, with Bolivia, Plurinational State of ahead.
- How many years of comparable data are there for Bolivia, Plurinational State of and Singapore?
- 16 years are reported by both, from 2007 to 2022.
- How do Bolivia, Plurinational State of and Singapore rank globally for treatment success rate for patients treated for mdr-tb?
- Bolivia, Plurinational State of ranks 149th and Singapore ranks 150th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.